• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
In the last 7 days
In the last month
Amgen, Merck, Teva Provide First-Quarter Biosimilars Info Center for Biosimilars15:59 30-Apr-21
Proposed Amgen project clears first hurdle in Thousand Oaks Ventura County Star, California EU14:08 29-Apr-21
Why Amgen Stock Is Plummeting Today The Motley Fool20:30 28-Apr-21
Amgen’s low-dose Kras curveball Evaluate Group16:05 28-Apr-21
Why Amgen's Q1 Results Disappointed Investors The Motley Fool11:11 28-Apr-21
Why Amgen’s Earnings Disappointed Barron's Online23:08 27-Apr-21
Amgen Earnings, Revenue Miss in Q1 Investing.com22:02 27-Apr-21
Amgen: Q1 Earnings Snapshot Bellingham Herald21:16 27-Apr-21
Amgen Announces Webcast Of 2021 First Quarter Financial Results PR Newswire (Press Release)21:03 22-Apr-21
BioAge licenses Amgen drug to treat muscle aging Longevity Technology12:05 14-Apr-21
Divided opinion PharmaTimes08:27 13-Apr-21
view more headlines
7 May 21:08

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.